Trial intelligence / Profile preview

Articaine Ophthalmic Solution for Corneal Endothelium Health

NCT07838129Phase 4Not yet recruiting

Sponsor
Laboratoires Théa
Start
Jan 2027
Primary completion
Dec 2027
01

Overview

A Phase 4 trial of articaine, sponsored by Laboratoires Théa. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

articaine

Beyond the preview

Go deeper on NCT07838129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07838129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call